INZY - Inozyme Pharma, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
8/3/23 20:13	8/1/23	INZY	Health	Drug	Pharmaceutical Preparations	Pivotal Bioventure Partners Fund I, L.P.	CA	D		P	4,000	4.80	833	113	1,572	I
8/3/23 20:01	8/1/23	INZY	Health	Drug	Pharmaceutical Preparations	Hopfner Robert Lorne	MA	D		P	4,000	4.80	833	113	1,572	I
5/15/23 17:06	5/11/23	INZY	Health	Drug	Pharmaceutical Preparations	Hopfner Robert Lorne	MA	D		P.m	2,850	6.36	448	14	3,662	I
3/30/23 17:46	3/29/23	INZY	Health	Drug	Pharmaceutical Preparations	Hopfner Robert Lorne	MA	D		P	1,564	4.54	345	12	3,214	I
3/29/23 19:30	3/27/23	INZY	Health	Drug	Pharmaceutical Preparations	Hopfner Robert Lorne	MA	D		P.m	841	4.05	208	8	2,869	I
12/19/22 08:30	12/15/22	INZY	Health	Drug	Pharmaceutical Preparations	Bjarke Henric Bjorn	MA	O	SVP,COO	P	30	1.39	22	26	105	D
4/21/22 18:04	4/19/22	INZY	Health	Drug	Pharmaceutical Preparations	Longitude Capital Partners Iii, LLC	CA	T		P	5,000	3.69	1,355	48	4,174	I
4/20/22 18:22	4/19/22	INZY	Health	Drug	Pharmaceutical Preparations	Pivotal Bioventure Partners Fund I, L.P.	CA	D		P	3,948	3.69	1,070	67	2,661	I
4/20/22 16:05	4/19/22	INZY	Health	Drug	Pharmaceutical Preparations	Bjarke Henric Bjorn	MA	O	SVP,COO	P	100	3.69	27	51	81	D
4/20/22 16:05	4/19/22	INZY	Health	Drug	Pharmaceutical Preparations	Bolte Axel	MA	DO	CEO	P	250	3.69	68	36	259	D
4/20/22 16:05	4/19/22	INZY	Health	Drug	Pharmaceutical Preparations	Hopfner Robert Lorne	MA	D		P	3,948	3.69	1,070	67	2,661	I
4/20/22 16:05	4/19/22	INZY	Health	Drug	Pharmaceutical Preparations	Subramanian Sanjay	MA	O	SVP,CFO	P	100	3.69	27	New	27	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person